Ticker
AVIRCompany Name
ATEA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 274.58M | $ -14.32M | $ 0 | $ 0 | 5.22% |
3/31/2025 | $ 253.32M | $ 255K | $ 0 | $ 0 | -0.1% |
12/31/2024 | $ 256.58M | $ 267K | $ 0 | $ 0 | -0.1% |
9/30/2024 | $ 290.55M | $ 267K | $ 0 | $ 0 | -0.09% |
6/30/2024 | $ 276.06M | $ 242K | $ 0 | $ 0 | -0.09% |
3/31/2024 | $ 333.52M | $ 242K | $ 0 | $ 0 | -0.07% |
12/31/2023 | $ 367.8M | $ 257K | $ 0 | $ 0 | -0.07% |
9/30/2023 | $ 274.5M | $ 257K | $ 0 | $ 0 | -0.09% |
6/30/2023 | $ 284.39M | $ 312K | $ 0 | $ 0 | -0.11% |
3/31/2023 | $ 283.56M | $ 312K | $ 0 | $ 0 | -0.11% |
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for ATEA PHARMACEUTICALS INC is calculated as follows: (-1 * CF - Equity [ $ -15K ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 0 ]) / Market Cap [ $ 0 ]
(=) Shareholder Yield [ 0% ]
Minimum
Sep 30, 2021
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.49K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.58% |
median | 1.07% |
std | 11.13% |